The physician-led clinical trial will start 2017 at Kyushu University under Kohei SONODA on incorporating human pigment epithelium-derived factor within a therapeutic vector to human patients. 5 years of animal experiments on this procedure did indicate no problems.
Nikkei Biotech news release, July 22, 2016
ID Pharma to supply vector for clinical trial of gene therapy for retinitis pigmentosa